The one of a kind database called ‘Ab-CoV’ contains detailed information about all COVID-related antibodies identified so far, including the source of each.
Team from Maulana Azad Medical College collected blood samples from 27,811 participants in Delhi between 24 September & 14 October 2021. Report on findings shared with govt earlier.
REGEN-COV received emergency use authorisation from US FDA. It is meant to treat mild-to-moderate Covid patients who aren't on oxygen support but who may be at risk of severe disease.
Vaccines often require boosters, but they aren’t our only option & in some cases may not even be our best. Fortunately, there’s another promising option: monoclonal antibody treatment.
According to Neelkanth Mishra, a top official at Credit Suisse, many districts could have herd immunity. However he noted this was just a hypothesis and an actual sero survey should follow.
A US study looked at bone marrow of recovered Covid patients and found plasma cells that can specifically recognise the spike protein of the coronavirus, upto 11 months after infection.
Several studies have compared the difference between antibodies produced after Covid and those that can be detected six months later. The findings are impressive.
Monoclonal antibodies are man-made proteins made to mimic the body’s immune response to a pathogen. The mutant strains are found to throw off these antibodies.
DMK govt accuses Centre of withholding funds, tightening borrowing, unilateral deductions from state accounts. Says Centre's accounting & funding decisions have 'artificially inflated' debt burden.
This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they’d seen marginal interest. The starkest example is India & Europe.
COMMENTS